Marquet P - Search Results

1

Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.

Loustaud-Ratti V, Alain S, Rousseau A, Hubert IF, Sauvage FL, Marquet P, Denis F, Lunel F, Calès P, Lefebvre A, Fauchais AL, Liozon E, Vidal E. Loustaud-Ratti V, et al. Among authors: marquet p. Hepatology. 2008 May;47(5):1453-61. doi: 10.1002/hep.22217. Hepatology. 2008. PMID: 18435468 Free article.

2

Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry.

Rousseau A, Marquet P, Comby F, Buxeraud J, Raby C, Lachâtre G. Rousseau A, et al. Among authors: marquet p. J Chromatogr B Biomed Sci Appl. 1997 May 23;693(1):93-100. doi: 10.1016/s0378-4347(97)00052-2. J Chromatogr B Biomed Sci Appl. 1997. PMID: 9200522

3

Relationship between psychotropic drugs and thyroid function: a review.

Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachâtre G. Sauvage MF, et al. Among authors: marquet p. Toxicol Appl Pharmacol. 1998 Apr;149(2):127-35. doi: 10.1006/taap.1998.8367. Toxicol Appl Pharmacol. 1998. PMID: 9571980 Review.

4

Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration.

Rousseau A, Marquet P, Lagorce JF, Sauvage MF, Buxeraud J, Lachâtre G, Raby C. Rousseau A, et al. Among authors: marquet p. Pharmacology. 1998 Nov;57(5):242-8. doi: 10.1159/000028248. Pharmacology. 1998. PMID: 9742289

5

In vitro and in vivo study of the antithyroid side effects of trimeprazine.

Sauvage MF, Rousseau A, Marquet P, Dumeirain F, Raby C, Lachâtre G. Sauvage MF, et al. Among authors: marquet p. Toxicol Appl Pharmacol. 1999 Jul 15;158(2):125-31. doi: 10.1006/taap.1999.8699. Toxicol Appl Pharmacol. 1999. PMID: 10406927

6

Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.

Ragot S, Marquet P, Lachâtre F, Rousseau A, Lacassie E, Gaulier JM, Dupuy JL, Lachâtre G. Ragot S, et al. Among authors: marquet p. J Chromatogr B Biomed Sci Appl. 1999 Dec 24;736(1-2):175-84. doi: 10.1016/s0378-4347(99)00452-1. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10676997

7

Adaptive control methods for the dose individualisation of anticancer agents.

Rousseau A, Marquet P, Debord J, Sabot C, Lachâtre G. Rousseau A, et al. Among authors: marquet p. Clin Pharmacokinet. 2000 Apr;38(4):315-53. doi: 10.2165/00003088-200038040-00003. Clin Pharmacokinet. 2000. PMID: 10803455 Review.

8

Sensitive determination of vinorelbine and its metabolites in human serum using liquid chromatography-electrospray mass spectrometry.

Ragot S, Sauvage FL, Rousseau A, Genet D, Dupuy JL, Tubiana-Mathieu N, Marquet P. Ragot S, et al. Among authors: marquet p. J Chromatogr B Biomed Sci Appl. 2001 Apr 5;753(2):167-78. doi: 10.1016/s0378-4347(00)00408-4. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11334329

9

Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants.

Leger F, Debord J, Le Meur Y, Rousseau A, Büchler M, Lachâtre G, Paintaud G, Marquet P. Leger F, et al. Among authors: marquet p. Clin Pharmacokinet. 2002;41(1):71-80. doi: 10.2165/00003088-200241010-00006. Clin Pharmacokinet. 2002. PMID: 11825098 Clinical Trial.

10

An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine.

Prémaud A, Rousseau A, Gicquel M, Ragot S, Manceau J, Laurentie M, Marquet P. Prémaud A, et al. Among authors: marquet p. Toxicol Appl Pharmacol. 2002 Sep 15;183(3):189-97. doi: 10.1006/taap.2002.9467. Toxicol Appl Pharmacol. 2002. PMID: 12383710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

578 results

Search Page

Filters